Snellgrove Darren

SVP, Chief Financial Officer

Officer

Latest Insider Transactions

1 transactions (past 365 days)

HALO
CFO
Award
$9.8M
127,432 shares @ $77.01
Filed 2026-07-02Trade 2026-07-01
Halozyme Therapeutics, Inc.